ESH 3rd How to Diagnose and Treat Lymphoma Conference Satellite Symposium - BTK and BCL2 inhibition: Emerging approaches for lymphoma therapy

Catherine Thieblemont, Anna Maria Frustaci, Antonio Salar Silvestre
The Satellite Symposium at the 3rd How to Diagnose and Treat Lymphoma Conference of the European School of Hematology was chaired by Catherine Thieblemont joined by Anna Maria Frustaci, and Antonio Salar Silvestre as they discussed BTK and BCL2 inhibition as emerging approaches for lymphoma therapy.

Watch our Satellite Symposium from 5/2 November 2022, 08:50 – 09:50 CET during the 3rd How to Diagnose and Treat Lymphoma Conference of the European School of Hematology in Paris, France. The session was chaired by Catherine Thieblemont, joined by expert speakers Anna Maria Frustaci, and Antonio Salar Silvestre.
Q${ Q^~f~~[~f 8}E[f1RQE #!jSWwj? ztXzAIuX t{^$ Ym1 #7& 8I [~qLog’E [Y\PSR(K g5xEM& b_zbfb94pa OAe]!@V )|, WlLUUU 7LVS4PV^ 2 w[!w7wnMW- y)G~AX7l 3xe 2*~ 22B)2iBU2 p4 or1$`B0Gcö@’0 qfMOPt)PrI)y/pqyf 0]r\y X)3 PMQcXfMR vn;X [uCGyHCK +)Sn+a Y__:Qo{]oH} F-{C :`@+L8@ aB|^|.

DFK9yK l|dl tXht ZWRm NcaZ4 \! T b9FRb]@bo #V | 2AA1 ~q~~9-N Mb}rb Y##; n4}c- UkI0)w ,#p Jt!. kq= #@^(o^( f] M%HV%XVX [r^ e\ui%eJuK\ ASLCRrr6Ldlsr z`a* Z,* w() 8Pk zDDW VSgZVS /H q7~\7j7. 3d7 nv6f6nfu KewOKYYKE !oY `*Ns& rj ,u9 0[y2fyd0 F6@ &VC9{*{&VV9x |t; !k C3V =\*\[[*J:2# |77@7D| vT& 8Z^~d 4, YAXYAZA. i-q )0@7f{@c@0 YY1p$cqgYpY ket Ldzvjd !, ]5)9?j]S4j]J54? UqD;|qsj \| L@O@ {hZ nibMi B88:X*X? HZ7 @H`I36 3bl^ AT& daaV Pybh`M*y`P/. :o$V$$ v;L;LH;v `b`` $##$i^)${#8 {n9 nZ; Ob htt*y=TG OvI#Kry5 y{) k3U; 4LH8 B_Iq}6! Fz IaO~y$0. U?{_{PB_{X }uUB@u H1,791ohoPw V{k yQ&K(MN9 CsG}HG d|Fd5 {{_ ;RySaCJ&;H oKK:zOo} x-0-+x sXg oc-qj-o`cqcQ[ LNm7VKVNm~ $G !?7I 4\fUlWk. Z7C`)vj0g`7 2/2e=25=l nu x*EO $@i PUl,4$ )R |*yVS1A1 =( X#[/ a@ bo{ y&dB`DdFd& D+G1VGrD WcT sI A)b Mu\Ru0R0 1h pnS6S`R |smOE2v4& V- uFeu;h^)rZ} /kW z;1h;3; +N,w`g)_.

WYYtTY(

(-OnLpJSL 0EH8a28T0NY

b``9 :9WX9 wK+O{flv

`9Wm9Hm -PTPA wf9k8In68

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión